2005-08-24Zeitschriftenartikel DOI: 10.1002/jmv.20441
Respiratory disease caused by a species B2 adenovirus in a military camp in Turkey.
In April 2004, two patients were admitted to hospital in Berlin, Germany, with clinical signs of acute respiratory infection after returning from a military exercise in their home country of Turkey. They were admitted to a high security infectious disease unit as epidemiological data pointed to an outbreak of unknown etiology. Samples taken at the time of admission proved to be strongly positive for Adenovirus by PCR, but negative for Influenza A/H1N1 virus, Influenza A/H3N2 virus, Influenza B virus, Respiratory syncytial virus, and SARS coronavirus. No evidence for bacterial infection was obtained by serological tests and blood cultures. The adenovirus detected was characterized further by genotyping and was identified as a species B2 virus with the highest similarity to adenovirus type 11a.
Dateien zu dieser Publikation
Anzeige der Publikationen mit ähnlichem Titel, Autor, Urheber und Thema.
2016-09-16ZeitschriftenartikelBrincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation Voigt, Sebastian; Hofmann, Jörg; Edelmann, Anke; Sauerbrei, Andreas; Kühl, J. S.Infections with adenovirus (AdV) and herpesviruses can result in considerable morbidity and mortality in pediatric hematopoietic stem cell transplant (SCT) recipients. Herpes simplex virus (HSV) reactivations are usually ...
2015-08-13ZeitschriftenartikelAge-related prevalence of cross-reactive antibodies against influenza A(H3N2) variant virus, Germany, 2003 to 2010 Blümel, Benjamin; Schweiger, Brunhilde; Dehnert, Manuel; Buda, Silke; Reuss, Annicka; Czogiel, Irina; Kamtsiuris, Panagiotis; Schlaud, Martin; Poethko-Müller, Christina; Thamm, Michael; Haas, WalterTo estimate susceptibility to the swine-origin influenza A(H3N2) variant virus (A(H3N2)v) in the German population, we investigated cross-reactive antibodies against this virus and factors associated with seroprotective ...
2011-07-18ZeitschriftenartikelEffectiveness of the AS03-Adjuvanted Vaccine against Pandemic Influenza Virus A/(H1N1) 2009 - A Comparison of Two Methods; Germany, 2009/10. Uphoff, Helmut; Heiden, Matthias an der; Schweiger, Brunhilde; Campe, Hartmut; Beier, Dietmar; Helmeke, Carina; Littmann, Martina; Haas, Walter; Buda, Silke; Faensen, Daniel; Feig, Marcel; Altmann, Doris; Wichmann, Ole; Eckmanns, Tim; Buchholz, UdoDuring the autumn wave of the pandemic influenza virus A/(H1N1) 2009 (pIV) the German population was offered an AS03- adjuvanted vaccine. The authors compared results of two methods calculating the effectiveness of the ...